Advertisement

Topics

4965 Post-approval Study

2014-07-23 21:09:59 | BioPortfolio

Summary

Safety and effectiveness will be summarized for the model 4965 lead.

Description

As part of the requirement to satisfy the PMA Conditions of Approval for the Medtronic Model 4965 CapSure Epi® Steroid-Eluting Unipolar Epicardial Pacing Lead, 50 adult subjects who are > 19 years old will be followed for one-year post-implant.

Study Design

Observational Model: Cohort

Conditions

Arrhythmia

Location

Birmingham
Alabama
United States

Status

Recruiting

Source

Medtronic Cardiac Rhythm Disease Management

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:09:59-0400

Clinical Trials [119 Associated Clinical Trials listed on BioPortfolio]

Novel Methods for Arrhythmia Detection

Aims Approximately 20-25% of strokes are of cardioembolic origin, atrial fibrillation (AF) being a significant cause of cardioembolic strokes. AF is often symptomless and intermittent, mak...

INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT

To describe the clinical indications for Reveal XT in diagnosis and continuous monitoring of arrhythmia and to explore the clinical applications and outcome of arrhythmia monitoring on pat...

Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias

The primary purpose of this study is to improve the quality of Magnetic Resonance Imaging in patients with heart arrhythmia. Investigators will recruit 105 patients with arrhythmia and 30 ...

Monitoring Arrhythmia Patients (IMPACT)

Prospective, multicenter, non-randomized study to determine the performance of NUVANT Mobile Cardiac Telemetry system in arrhythmia detection.

Efficacy of Dyno on Symptomatic Arrhythmia

Participants in the Dyno arm were instructed to undertake once-day recording and transmission of a 30-second single-lead iECG trace to a secure server, plus additional submissions if sympt...

PubMed Articles [247 Associated PubMed Articles listed on BioPortfolio]

Insights on the pulmonary artery-derived ventricular arrhythmia.

Pulmonary artery-derived ventricular arrhythmia is gradually being recognized, which in a clinical context is recognized as an arterial ectopic beat. Our study aimed to provide new insights on the epi...

Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

This meta-analysis was conducted to evaluate the association between Attention deficit hyperactivity disorder (ADHD) medications and risk of sudden death/arrhythmia, stroke, myocardial infarction as w...

Osborn waves following out-of-hospital cardiac arrest-Effect of level of temperature management and risk of arrhythmia and death.

The Osborn or J-wave, an upright deflection of the J-point on the electrocardiogram (ECG), is often observed during severe hypothermia. A possible relation between Osborn waves (OW) and increased risk...

Association between activities of SOD, MDA and Na-K-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia.

Acute myocardial infarction (AMI) complicated by arrhythmia is a risk factor for exacerbating AMI disease and high fatality rate. The ability of the organism to resist oxidative stress is weak and the...

"What Cannot be Missed": a New Service of Arrhythmia and Electrophysiology Review.

Medical and Biotech [MESH] Definitions

A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients.

A naturally occurring variation in heart rate that occurs during a BREATHING cycle, where the time between heartbeats is shortened during inspiration and prolonged during expiration. It is not the same as SINUS ARRHYTHMIA, the disorder.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

A calcium channel blocker that is a class IV anti-arrhythmia agent.

A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage.

More From BioPortfolio on "4965 Post-approval Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Searches Linking to this Trial